Darnitsa Acting as a Partner in Organizing a Webinar for Physicians with a World-Class Expert

Darnitsa Pharmaceutical Company acted as a partner in organizing a webinar for physicians with the involvement of Pascal Proot, Head of the Headache Center in the Netherlands, on the treatment of migraine attacks. The event aroused a great interest in the neurological community

On October 28, 2021, a webinar on the topic "Treatment of Migraine Attacks - How to Provide Patients with a Better Level of Care” was held with the participation of the following speakers:

• Pascal Proot, the Founder and Head of Zeeland Headache Center (Netherlands), Research Consultant at the University Hospital of Ghent (Belgium), Chief Neurologist at Zorgsaam Zeeuws Vlaanderen Clinic (Belgium);
• Vadym Vasylovych Biloshytskyi, Doctor of Medical Sciences, Deputy Director for Research at Romodanov Neurosurgery Institute of the National Academy of Medical Sciences of Ukraine, Head of the Chronic Pain Treatment Group.**

The event aroused a great interest in the neurological community. The webinar was intended exclusively for healthcare professionals: neurologists, family doctors and other specialists. The event brought together more than 360 doctors in a live broadcast. And the organizers received more than 200 reviews with positive comments on the relevance of the topic and productive discussion. For those professionals who did not have time to register or could not attend, there is an opportunity to watch the record of the webinar.

The key topics covered at the webinar:

• The burden of migraine in today’s world – open questions and unsatisfied needs
• Migraine treatment – an overview of current approaches and options
• Patient-oriented approach in the treatment of migraine attacks
• Successful strategies in managing a migraine patient – clinical analysis

The event was organized by RIMON Charitable Foundation for Medical Innovation Development and Projects Inn LLC with the support of Darnitsa Pharmaceutical Company.

“According to the WHO, the prevalence of headaches among adults is about 50%. And over 30% of those who have a headache talk about migraines. Darnitsa Pharmaceutical Company aims to bring the world experience in combating migraines to Ukraine and help to improve the expertise of physicians in this area,” said Lidiia Honchar-Cherdakli, Candidate of Medical Sciences, Deputy Medical Director of Darnitsa Pharmaceutical Company.

Background information

Darnitsa Pharmaceutical Company PrJSC was established in 1930. Since 1998, Darnitsa has been the leader in Ukraine in terms of production of drugs by volume. Strategic areas of portfolio development include cardiology, neurology and pain management. During 2015-2020, Darnitsa launched 50 pharmaceutical brands.

* The above information is intended solely for distribution in specialized publications intended for healthcare institutions and physicians, as well as at medical conferences and seminars.

** Pascal Proot, has been the Founder and Head of Zeeland Headache Center (Netherlands) since 2011, the Research Consultant at the University Hospital of Ghent since 2009, the Chief Neurologist at Zorgsaam Zeeuws Vlaanderen Clinic, Ghent, Belgium. He has also been practicing at a private clinic in Merelbeke (Belgium) since 2015. A member of the Dutch Neurological Association, American Academy of Neurophysiology and Electrodiagnostic Medicine, Dutch Headache Association. Pascal Proot is the author of numerous scientific papers.

Vadym Vasylovych Biloshytskyi, Doctor of Medical Sciences is the Deputy Director for Research at Romodanov Neurosurgery Institute of the National Academy of Medical Sciences of Ukraine, Head of the Chronic Pain Treatment Group. He is the author and co-author of more than 100 scientific papers, including monographs; a member of the Ukrainian Association of Neurosurgeons, the European and World Associations of Neurosurgeons, the International Association for the Study of Pain (IASP), the Ukrainian Association for the Study of Pain and the Ukrainian Society for Pain Management; an Associate Member of the World Institute of Pain.